Got 90 seconds? Then listen to Osteopore executive director Geoff Pocock discuss the company’s innovative medical technology and plans post-IPO.

Osteopore (ASX:OSX) is a medical technology company aiming to commercialise a range of products focused on  improving bone healing across a range of therapeutic areas.

Through a combination of 3-D printing and bioresorbable material, Osteopore manufactures devices that mimic bone microarchitecture and help facilitate natural bone healing. The company’s products have been used in over 20,000 successful treatments, with complication rates much lower than traditional permanent bone implants.

Osteopore aims to raise $5.25m in a September IPO, with the additional funding to be put towards further business expansion into key international markets.

Stockhead gave Osteopore executive director Geoff Pocock 90 seconds to discuss the company’s core technology and plans after the September IPO.

Have a good idea for our next 90 Seconds With segment? Email us at tv@stockhead.com.au.